Raymond James Financial Services Advisors’s Avanos Medical AVNS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,048	Closed	-$351K	–	2823
2019 Q2	$351K	Buy	+8,048	New	+$344K	﹤0.01%	2166
2019 Q1	–	Sell	-4,743	Closed	-$212K	–	2800
2018 Q4	$212K	Sell	4,743 -23	-0.5%	-$1.21K	﹤0.01%	2219
2018 Q3	$326K	Buy	4,766 +256	+6%	+$16.5K	﹤0.01%	2220
2018 Q2	$258K	Buy	+4,510	New	+$238K	﹤0.01%	2336
2017 Q4	–	Sell	-4,796	Closed	-$216K	–	2541
2017 Q3	$216K	Sell	4,796 -741	-13%	-$31.6K	﹤0.01%	2227
2017 Q2	$217K	Buy	+5,537	New	+$209K	﹤0.01%	2169

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial Services Advisors's AVNS Position: Q3 2019 in Review

Raymond James Financial Services Advisors sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 8,048 shares — an estimated $351K sold.

Raymond James Financial Services Advisors first reported a position in AVNS in Q2 2017 and held it in 6 quarters. The position peaked at $351K in Q2 2019. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Raymond James Financial Services Advisors reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
Raymond James Financial Services Advisors sold 8,048 Avanos Medical shares in Q3 2019, an estimated $351K.
Raymond James Financial Services Advisors first reported a position in Avanos Medical in Q2 2017 and held it in 6 quarters.
Raymond James Financial Services Advisors's Avanos Medical position peaked at $351K in Q2 2019.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2019, filed 7 Nov 2019.